During the past decade, Fox Chase Cancer Center Extramural Research Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center Extramural Research Program" #1 collaborator was "Hoosier Cancer Research Network" with 2 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center Extramural Research Program" are "Bladder Cancer" (1 trials), "Lung Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Fox Chase Cancer Center Extramural Research Program" in a lesser frequency.

Most popular intervention types in "Fox Chase Cancer Center Extramural Research Program" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amrubicin" (1 trials), "Bevacizumab" (1 trials), "Cyclophosphamide" (1 trials), "Dovitinib" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fox Chase Cancer Center Extramural Research Program" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fox Chase Cancer Center Extramural Research Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fox Chase Cancer Center Extramural Research Program, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fox Chase Cancer Center Extramural Research Program, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".